Atrial High-Rate Episodes, Subclinical Atrial Fibrillation and Short-Duration Clinical Atrial Fibrillation: Different Names for the Same Arrhythmia or a New Player On the Pitch?
- PMID: 33154932
- PMCID: PMC7640548
- DOI: 10.37616/2212-5043.1119
Atrial High-Rate Episodes, Subclinical Atrial Fibrillation and Short-Duration Clinical Atrial Fibrillation: Different Names for the Same Arrhythmia or a New Player On the Pitch?
Keywords: Anticoagulation; Atrial Fibrillation; Atrial high-rate episodes; Subclinical atrial fibrillation.
Conflict of interest statement
Authors declare no conflicts of interest. This paper did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Similar articles
-
How should I treat patients with subclinical atrial fibrillation and atrial high-rate episodes? Current evidence and clinical importance.Clin Res Cardiol. 2022 Sep;111(9):994-1009. doi: 10.1007/s00392-022-02000-7. Epub 2022 Mar 15. Clin Res Cardiol. 2022. PMID: 35292844 Free PMC article. Review.
-
Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future.Medicina (Kaunas). 2019 Sep 20;55(10):611. doi: 10.3390/medicina55100611. Medicina (Kaunas). 2019. PMID: 31547078 Free PMC article. Review.
-
Subclinical atrial fibrillation - what is the risk of stroke?Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019 Jun;163(2):107-113. doi: 10.5507/bp.2018.083. Epub 2019 Jan 10. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019. PMID: 30631210 Review.
-
Management of device-detected atrial high-rate episodes.Card Electrophysiol Clin. 2015 Sep;7(3):515-25. doi: 10.1016/j.ccep.2015.05.010. Epub 2015 Jun 23. Card Electrophysiol Clin. 2015. PMID: 26304531 Review.
-
Clinical classification and the subclinical atrial fibrillation challenge: a position paper of the European Cardiac Arrhythmia Society.J Interv Card Electrophysiol. 2020 Dec;59(3):495-507. doi: 10.1007/s10840-020-00859-y. Epub 2020 Oct 13. J Interv Card Electrophysiol. 2020. PMID: 33048302 Review.
References
-
- Noseworthy PA, Kaufman ES, Chen LY, Chung MK, Elkind MSV, Joglar JA, et al. American Heart Association Council on Clinical Cardiology Electrocardiography and Arrhythmias Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and Stroke Council. Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association. Circulation. 2019;140:e944–63. doi: 10.1161/CIR.0000000000000740. - DOI - PMC - PubMed
-
- January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, Jr, et al. AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation. 2019;140:e125–51. 2019, https://doiorg/10.1161/CIR.0000000000000665. - DOI - PubMed
-
- Lopes RD, Alings M, Connolly SJ, Beresh H, Granger CB, Mazuecos JB, et al. Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial. Am Heart J. 2017;189:137–45. doi: 10.1016/j.ahj.2017.04.008. - DOI - PubMed
-
- Kirchhof P, Blank BF, Calvert M, Camm AJ, Chlouverakis G, Diener HC, et al. Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. Am Heart J. 2017;190:12–8. doi: 10.1016/j.ahj.2017.04.015. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources